Bio-Rad Laboratories, Inc.
BIO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,548,940 | $6,570,178 | $6,805,310 | $9,197,294 |
| - Cash | $397,800 | $369,300 | $521,400 | $488,100 |
| + Debt | $1,395,300 | $1,406,500 | $1,369,500 | $1,374,700 |
| Enterprise Value | $8,546,440 | $7,607,378 | $7,653,410 | $10,083,894 |
| Revenue | $653,000 | $651,600 | $585,400 | $667,475 |
| % Growth | 0.2% | 11.3% | -12.3% | – |
| Gross Profit | $343,400 | $345,300 | $306,000 | $341,912 |
| % Margin | 52.6% | 53% | 52.3% | 51.2% |
| EBITDA | -$384,600 | $477,200 | $133,500 | -$847,400 |
| % Margin | -58.9% | 73.2% | 22.8% | -127% |
| Net Income | -$341,900 | $317,800 | $64,000 | -$715,800 |
| % Margin | -52.4% | 48.8% | 10.9% | -107.2% |
| EPS Diluted | -12.7 | 11.67 | 2.29 | -25.57 |
| % Growth | -208.8% | 409.6% | 109% | – |
| Operating Cash Flow | $120,900 | $116,500 | $129,900 | $124,152 |
| Capital Expenditures | -$31,700 | -$45,700 | -$34,400 | -$42,904 |
| Free Cash Flow | $89,200 | $70,800 | $95,500 | $81,248 |